http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11246948-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49f04b1dc6b9fcc2d8b159c5ebee364b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c8d6330b4f1eab320f7191d0d191a3a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-037
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0071
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-00
filingDate 2018-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_922dee35ec417b2f7da0349a3cc4b753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4dea00b55630fbdba60d1f79ebb547f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_373c7e47206ab20170025800329c79d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f91dd35673723140e4e94938b339c5f
publicationDate 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11246948-B2
titleOfInvention Method of evaluating lymphatic system function
abstract An embodiment relates to a method of evaluating a lymphatic system function including: selecting one or a plurality of lymphatic routes to be evaluated from a plurality of lymphatic routes existing in four limbs; determining an injection site of a visualization agent based on information on the selected lymphatic route and injection sites of peripheries of the four limbs corresponding to the selected lymphatic route; injecting the visualization agent from the selected injection site; and visualizing the injected visualization agent and evaluating functions of the one or plurality of lymphatic routes to be evaluated.
priorityDate 2018-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407215665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410110416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID890
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411168116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414854372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425741

Total number of triples: 43.